Literature DB >> 17870112

Variability of Oxalobacter formigenes and oxalate in stool samples.

Sergey Prokopovich1, John Knight, Dean G Assimos, Ross P Holmes.   

Abstract

PURPOSE: The intestinal organism Oxalobacter formigenes is unique in using oxalate as its primary carbon and energy source. Intestinal colonization with O. formigenes may have clinical significance by decreasing intestinal oxalate and its absorption, thereby influencing the concentration of oxalate in plasma and urine, and the development of calcium oxalate stone disease. Because the oxalate content of the diet varies considerably, we hypothesized that the number of O. formigenes and amount of oxalate would vary in feces.
MATERIALS AND METHODS: To enumerate the number of O. formigenes in feces an accurate and reproducible real-time polymerase chain reaction assay was developed to quantify O. formigenes DNA. Stool samples were obtained from 10 colonized individuals to determine the levels of O. formigenes by this assay and the oxalate content by ion chromatography.
RESULTS: Concentrations of O. formigenes ranged from lower than the limit of detection of 5 x 10(3) to 1.04 x 10(9) cells per gm stool. The total oxalate content of stool samples varied from 0.1 to 1.8 mg/gm and fecal water oxalate varied from 60 to 600 microM. All parameters measured varied within each stool collection, among stool collections on different days and among individuals. Notably in 7 of 10 individuals at least 1 stool sample contained no detectable O. formigenes. In addition, 7 of 10 subjects had a fecal colonization of less than 4 x 10(4) per gm stool.
CONCLUSIONS: This study demonstrates that there is intrastool and interstool sample variability in the amount of O. formigenes measured by real-time polymerase chain reaction that did not correlate with the quantity of oxalate in stool. Most subjects had a fecal colonization of less than 4 x 10(4) per gm stool.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17870112      PMCID: PMC2637797          DOI: 10.1016/j.juro.2007.06.045

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

1.  Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.

Authors:  H Sidhu; M E Schmidt; J G Cornelius; S Thamilselvan; S R Khan; A Hesse; A B Peck
Journal:  J Am Soc Nephrol       Date:  1999-11       Impact factor: 10.121

2.  Distribution of bacteria in feces of swine.

Authors:  G D Rall; A J Wood; R B Wescott; A R Dommert
Journal:  Appl Microbiol       Date:  1970-11

3.  Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1.

Authors:  B Hoppe; B Beck; N Gatter; G von Unruh; A Tischer; A Hesse; N Laube; P Kaul; H Sidhu
Journal:  Kidney Int       Date:  2006-07-19       Impact factor: 10.612

4.  Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes.

Authors:  H Sidhu; M J Allison; J M Chow; A Clark; A B Peck
Journal:  J Urol       Date:  2001-10       Impact factor: 7.450

5.  Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis.

Authors:  Cheol Kwak; Hee Kyung Kim; Eui Chong Kim; Myung Sik Choi; Hyeon Hoe Kim
Journal:  Eur Urol       Date:  2003-10       Impact factor: 20.096

6.  Oxalate degradation by intestinal lactic acid bacteria in dogs and cats.

Authors:  J S Weese; H E Weese; L Yuricek; J Rousseau
Journal:  Vet Microbiol       Date:  2004-07-14       Impact factor: 3.293

7.  Comparison of bacterial populations of the pig cecum and colon based upon enumeration with specific energy sources.

Authors:  M J Allison; I M Robinson; J A Bucklin; G D Booth
Journal:  Appl Environ Microbiol       Date:  1979-06       Impact factor: 4.792

8.  Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract.

Authors:  M J Allison; K A Dawson; W R Mayberry; J G Foss
Journal:  Arch Microbiol       Date:  1985-02       Impact factor: 2.552

9.  Oxalate degradation by gastrointestinal bacteria from humans.

Authors:  M J Allison; H M Cook; D B Milne; S Gallagher; R V Clayman
Journal:  J Nutr       Date:  1986-03       Impact factor: 4.798

10.  Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.

Authors:  Scott A Troxel; Harmeet Sidhu; Poonam Kaul; Roger K Low
Journal:  J Endourol       Date:  2003-04       Impact factor: 2.942

View more
  10 in total

1.  Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes.

Authors:  Viktoria Kharlamb; Jennifer Schelker; Fritz Francois; Juquan Jiang; Ross P Holmes; David S Goldfarb
Journal:  J Endourol       Date:  2011-10-21       Impact factor: 2.942

2.  Quantitative analysis of colonization with real-time PCR to identify the role of Oxalobacter formigenes in calcium oxalate urolithiasis.

Authors:  Ertan Batislam; Erdal Yilmaz; Ercan Yuvanc; Ozgul Kisa; Ucler Kisa
Journal:  Urol Res       Date:  2012-01-04

3.  Presence of Oxalobacter formigenes in the intestinal tract is associated with the absence of calcium oxalate urolith formation in dogs.

Authors:  Josephine S Gnanandarajah; Juan E Abrahante; Jody P Lulich; Michael P Murtaugh
Journal:  Urol Res       Date:  2012-01-06

4.  The Relationship between Serum Oxalic Acid, Central Hemodynamic Parameters and Colonization by Oxalobacter formigenes in Hemodialysis Patients.

Authors:  Baris Gulhan; Kultigin Turkmen; Merve Aydin; Murat Gunay; Aytekin Cıkman; Murat Kara
Journal:  Cardiorenal Med       Date:  2015-04-17       Impact factor: 2.041

5.  Sensitivity of human strains of Oxalobacter formigenes to commonly prescribed antibiotics.

Authors:  Jessica N Lange; Kyle D Wood; Hayes Wong; Richard Otto; Patrick W Mufarrij; John Knight; Haluk Akpinar; Ross P Holmes; Dean G Assimos
Journal:  Urology       Date:  2012-06       Impact factor: 2.649

6.  The construction of an oxalate-degrading intestinal stem cell population in mice: a potential new treatment option for patients with calcium oxalate calculus.

Authors:  Zhiqiang Chen; Guanlin Liu; Zhangqun Ye; Debo Kong; Lingfang Yao; Hui Guo; Weimin Yang; Xiao Yu
Journal:  Urol Res       Date:  2011-09-03

7.  Effects of Lactobacillus casei and Bifidobacterium breve on urinary oxalate excretion in nephrolithiasis patients.

Authors:  Renato Ribeiro Nogueira Ferraz; Natália Cristina Marques; Leila Froeder; Viviane Barcellos Menon; Priscila Reina Siliano; Alessandra Calábria Baxmann; Ita Pfeferman Heilberg
Journal:  Urol Res       Date:  2009-02-12

8.  Low Oxalobacter Formigenes Colonization is Associated with Reduced Bone Mineral Density in Urinary Stone Forming Patients.

Authors:  Sadrettin Pence; Ibrahim Ikizceli; Emin Ozbek; Necip Ozan Tiryakioglu; Hilal Eren; Emre Can Polat; Halime Hanım Pence
Journal:  Curr Urol       Date:  2015-11-10

9.  Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures.

Authors:  Mangesh V Suryavanshi; Shrikant S Bhute; Swapnil D Jadhav; Manish S Bhatia; Rahul P Gune; Yogesh S Shouche
Journal:  Sci Rep       Date:  2016-10-06       Impact factor: 4.379

10.  Oxalate-Degrading Bacillus subtilis Mitigates Urolithiasis in a Drosophila melanogaster Model.

Authors:  Kait F Al; Brendan A Daisley; Ryan M Chanyi; Jennifer Bjazevic; Hassan Razvi; Gregor Reid; Jeremy P Burton
Journal:  mSphere       Date:  2020-09-09       Impact factor: 4.389

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.